Michael N. Taglich, Director at SCOLR Pharma, Inc. (DDD), bought 2,500 shares at $0.25 ($625) on 2009-03-17, disclosed to the SEC on 2009-03-19.
Open-market purchase of $625 DDD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| AIRI | SELL | 2024-09-17 | $49K | — | Filing → |
| BLIN | BUY | 2024-09-03 | $18K | — | Filing → |
| INLX | BUY | 2024-08-30 | $9K | — | Filing → |